| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07012044 A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With… |
Trial sites expanded: 2 -> 5 locations |
| 2026-05-28 | NCT07012044 A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With… |
Primary endpoint(s) modified |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
Enrollment reduced: 20 -> 1 participants |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Primary completion moved earlier: 2027-12-31 -> 2026-01-23 |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Completion moved earlier: 2027-12-31 -> 2026-10-15 |
| 2026-05-23 | NCT05139017 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… |
Trial sites expanded: 128 -> 131 locations |
| 2026-05-20 | NCT07012044 A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With… |
date change Primary completion pushed: 2027-01-01 -> 2027-03-31 |
| 2026-05-20 | NCT07012044 A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With… |
date change Completion pushed: 2027-01-01 -> 2027-03-31 |
| 2026-05-16 | NCT05139017 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… |
Trial sites expanded: 124 -> 128 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07637851 Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer | Phase 1/2 | Not Yet Recruiting |
| 2026-06-01 | NCT07616154 Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease | Phase 2 | Not Yet Recruiting |
| 2026-05-26 | NCT07605416 Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM… | Phase 2 | Not Yet Recruiting |
| 2026-05-22 | NCT07602777 A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-22 | NCT07604233 Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05753618 | Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients… | Early-stage Breast Cancer | Recruiting |
| NCT07101445 | Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the… | Multiple Myeloma | Recruiting |
| NCT01553214 | Improving White Blood Cell Collection From Healthy Donors | Allogeneic Granulocyte Donation | Recruiting |
| Phase 3 | |||
| NCT03480360 | Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT03182244 | A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory… | AML With FLT3 Mutation | Active, Not Recruiting |
| NCT03907488 | Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… | Ann Arbor Stage III Hodgkin Lymphoma | Active, Not Recruiting |
| NCT04759586 | Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed… | Primary Mediastinal Large B-Cell Lymphoma | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05139017 | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… | DLBCL | Recruiting |
| Phase 2 | |||
| NCT04370301 | Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… | Primary Myelofibrosis | Recruiting |
| NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | Fanconi Anemia | Recruiting |
| NCT07046078 | Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT05535166 | Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly… | Medulloblastoma | Recruiting |
| NCT06207799 | Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With… | Multiple Myeloma | Recruiting |
| NCT06059391 | CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT05796570 | A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant… | Acute Myeloid Leukemia | Recruiting |
| NCT00801489 | Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin… | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Recruiting |
| NCT01624805 | Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or… | Aplastic Anemia | Recruiting |
| NCT07224100 | Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of… | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Recruiting |
| NCT04684368 | A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT | Central Nervous System Nongerminomatous Germ Cell Tumor | Recruiting |
| NCT06649851 | G-CSF After Chemo-radiation in Patients With Glioblastoma | MGMT-Methylated Glioblastoma | Recruiting |
| NCT06926751 | Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced… | Solid Tumors | Recruiting |
| NCT06738368 | Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT06528691 | Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With… | High Grade Glioma | Recruiting |
| NCT04195633 | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… | Acute Leukemia | Recruiting |